- Home
- RFIL vs LENZ Comparison
RFIL vs LENZ Comparison
Compare RFIL & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RFIL | LENZ |
|---|---|---|
| Founded | 1979 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.3M | 155.5M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RFIL | LENZ |
|---|---|---|
| Price | $10.07 | $5.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $11.25 | ★ $44.00 |
| AVG Volume (30 Days) | 176.4K | ★ 697.1K |
| Earning Date | 06-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.59 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $55,325,000.00 | $19,088,000.00 |
| Revenue This Year | $9.65 | $50.42 |
| Revenue Next Year | $6.40 | $197.16 |
| P/E Ratio | $143.71 | ★ N/A |
| Revenue Growth | ★ 10.22 | N/A |
| 52 Week Low | $5.54 | $4.54 |
| 52 Week High | $22.30 | $50.19 |
Technical Indicators
Market Signals| Indicator | RFIL | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 30.60 | 64.35 |
| Support Level | $9.57 | $4.59 |
| Resistance Level | $13.59 | $6.18 |
| Average True Range (ATR) | 0.57 | 0.26 |
| MACD | -0.06 | 0.14 |
| Stochastic Oscillator | 2.38 | 84.54 |
Price Performance
Historical ComparisonAbout RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.